Nutex Health Inc. NUTX
Nutex Health Inc. statistics & valuation
Market cap$1.1B
P / E16.2×
P / S1.3×
P / B2.7×
P / FCF4.7×
Net margin8.1%
Return on equity16.7%
FCF margin28.1%
Net cash$156.4M
Net debt / EBITDA-0.5×
Enterprise value USD$988.7M
EV / EBITDA3.3×
Earnings yield EBIT/EV27.9%
Return on capital36.2%
Graham number -31.2%$118.70
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($118.70); a green figure means the price is below it.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 50.8% | 40.9% | 14.0% | 7.0% | 54.1% | 57.5% | 39.2% | 62.9% | -31.6% | — |
| Operating margin | 31.5% | 27.2% | -12.8% | -185.4% | 51.4% | 55.9% | -504.8% | -61.5% | -24574.5% | — |
| Net margin | 8.1% | 10.9% | -18.5% | -193.7% | 40.0% | 38.7% | -520.8% | -69.5% | 2512.6% | — |
| FCF margin | 28.1% | 4.3% | -3.3% | 16.4% | 41.2% | 9.3% | -301.9% | -35.1% | — | — |
| Return on assets | 7.7% | 7.9% | -11.5% | -98.4% | 33.6% | 62387.7% | -106.3% | -211.4% | 17.5% | -1454.9% |
| Return on equity | 16.7% | 27.6% | -57.9% | -353.0% | 69.2% | 71.9% | -14.0% | 63.5% | -58.4% | 126.6% |
| Debt / equity | 0.07× | 0.12× | 0.33× | 0.19× | 0.41× | 0.00× | 0.00× | -0.20× | — | — |
| Current ratio | 3.41 | 1.90 | 1.56 | 1.79 | 4.09 | 0.14 | 0.27 | 0.29 | 0.06 | 0.08 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.